🇺🇸 FDA
Pipeline program

Qvar

IXR-402-4-196

Approved small_molecule terminated

Quick answer

Qvar for Asthma is a Approved program (small_molecule) at Teva Pharma GmbH with 2 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials